PYC Chart looks the goods, page-111

"my thoughts are that a nasdaq listing might be the trigger as they like a higher share price than a few cents. The way they are going with a US office etc that would be sooner rather than later in my view."

Maybe the thought was for a US listing, but maybe put the timeframe back a bit from that hence the departure of Doug Huey.
If the political decision of MSB FDA approval is anything to go by, maybe a delay is a good thing under the current political climate.
I know for trials etc we need to be over there, and phase 3 trials have to be US based I believe, but we are a bit from that position as yet.

In the mean time, loving the steep green slope!